Работы, цитирующие эту работу

Работ: 2

Работа: Combining the induced pluripotent stem cell (iPSC) technology with chimeric antigen receptor (CAR)-based immunotherapy: recent advances, challenges, and future prospects

1. Emerging strategies to reduce the side effects of CAR-T cell therapy: focusing on gene editing and nanotechnology

   Jinxin Dong, Denis Nikolenko, Shuxrat Boymuradov +2

   СтатьяCAR-T cell therapy researchClinical & Translational Oncology2026Цитирований: 1

   ABIABI:AkademIndex/openalex/2026.article.000172

2. CAR-engineered neutrophils derived from induced pluripotent stem cells: a new frontier in cellular immunotherapy

   E. A Nemilostiva, O. A Paevskaya, Shuxrat Boymuradov +2

   СтатьяPluripotent Stem Cells ResearchClinical & Translational Oncology2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.018185